301 related articles for article (PubMed ID: 26824576)
41. Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder.
Richards C; Powis L; Moss J; Stinton C; Nelson L; Oliver C
J Neurodev Disord; 2017 Nov; 9(1):37. PubMed ID: 29126394
[TBL] [Abstract][Full Text] [Related]
42. Neurocognitive follow-up in adult siblings with Phelan-McDermid syndrome due to a novel SHANK3 splicing site mutation.
Kankuri-Tammilehto M; Sauna-Aho O; Arvio M
Mol Genet Genomic Med; 2021 Dec; 9(12):e1780. PubMed ID: 34369668
[TBL] [Abstract][Full Text] [Related]
43. Dissecting the 22q13 region to explore the genetic and phenotypic diversity of patients with Phelan-McDermid syndrome.
Vitrac A; Leblond CS; Rolland T; Cliquet F; Mathieu A; Maruani A; Delorme R; Schön M; Grabrucker AM; van Ravenswaaij-Arts C; Phelan K; Tabet AC; Bourgeron T
Eur J Med Genet; 2023 May; 66(5):104732. PubMed ID: 36822569
[TBL] [Abstract][Full Text] [Related]
44. Speech and language phenotype in Phelan-McDermid (22q13.3) syndrome.
Brignell A; Gu C; Holm A; Carrigg B; Sheppard DA; Amor DJ; Morgan AT
Eur J Hum Genet; 2021 Apr; 29(4):564-574. PubMed ID: 33293697
[TBL] [Abstract][Full Text] [Related]
45. Brief Report: Sensory Reactivity in Children with Phelan-McDermid Syndrome.
Mieses AM; Tavassoli T; Li E; Soorya L; Lurie S; Wang AT; Siper PM; Kolevzon A
J Autism Dev Disord; 2016 Jul; 46(7):2508-13. PubMed ID: 26914612
[TBL] [Abstract][Full Text] [Related]
46. Clinical and Genetic Aspects of Phelan-McDermid Syndrome: An Interdisciplinary Approach to Management.
Cammarata-Scalisi F; Callea M; Martinelli D; Willoughby CE; Tadich AC; Araya Castillo M; Lacruz-Rengel MA; Medina M; Grimaldi P; Bertini E; Nevado J
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328058
[TBL] [Abstract][Full Text] [Related]
47. 22q13 deletion syndrome: communication disorder or autism? Evidence from a specific clinical and neurophysiological phenotype.
Ponson L; Gomot M; Blanc R; Barthelemy C; Roux S; Munnich A; Romana S; Aguillon-Hernandez N; Malan V; Bonnet-Brilhault F
Transl Psychiatry; 2018 Aug; 8(1):146. PubMed ID: 30089781
[TBL] [Abstract][Full Text] [Related]
48. Deletion syndrome 22q13: what the dentist should know to manage children with Phelan-McDermid syndrome effectively.
Ivanoff C; Ivanoff AE
J Tenn Dent Assoc; 2014; 94(1):15-8; quiz 19-20. PubMed ID: 25241497
[TBL] [Abstract][Full Text] [Related]
49. Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome.
Mitz AR; Philyaw TJ; Boccuto L; Shcheglovitov A; Sarasua SM; Kaufmann WE; Thurm A
Eur J Hum Genet; 2018 Mar; 26(3):293-302. PubMed ID: 29358616
[TBL] [Abstract][Full Text] [Related]
50. Consensus recommendations on mental health issues in Phelan-McDermid syndrome.
van Balkom IDC; Burdeus-Olavarrieta M; Cooke J; de Cuba AG; Turner A; ; Vogels A; Maruani A
Eur J Med Genet; 2023 Jun; 66(6):104770. PubMed ID: 37085014
[TBL] [Abstract][Full Text] [Related]
51. Genetic and metabolic profiling of individuals with Phelan-McDermid syndrome presenting with seizures.
Jain L; Oberman LM; Beamer L; Cascio L; May M; Srikanth S; Skinner C; Jones K; Allen B; Rogers C; Phelan K; Kaufmann WE; DuPont B; Sarasua SM; Boccuto L
Clin Genet; 2022 Jan; 101(1):87-100. PubMed ID: 34664257
[TBL] [Abstract][Full Text] [Related]
52. Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome.
Bonaglia MC; Giorda R; Beri S; De Agostini C; Novara F; Fichera M; Grillo L; Galesi O; Vetro A; Ciccone R; Bonati MT; Giglio S; Guerrini R; Osimani S; Marelli S; Zucca C; Grasso R; Borgatti R; Mani E; Motta C; Molteni M; Romano C; Greco D; Reitano S; Baroncini A; Lapi E; Cecconi A; Arrigo G; Patricelli MG; Pantaleoni C; D'Arrigo S; Riva D; Sciacca F; Dalla Bernardina B; Zoccante L; Darra F; Termine C; Maserati E; Bigoni S; Priolo E; Bottani A; Gimelli S; Bena F; Brusco A; di Gregorio E; Bagnasco I; Giussani U; Nitsch L; Politi P; Martinez-Frias ML; Martínez-Fernández ML; Martínez Guardia N; Bremer A; Anderlid BM; Zuffardi O
PLoS Genet; 2011 Jul; 7(7):e1002173. PubMed ID: 21779178
[TBL] [Abstract][Full Text] [Related]
53. Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome).
Reierson G; Bernstein J; Froehlich-Santino W; Urban A; Purmann C; Berquist S; Jordan J; O'Hara R; Hallmayer J
J Psychiatr Res; 2017 Aug; 91():139-144. PubMed ID: 28346892
[TBL] [Abstract][Full Text] [Related]
54. Sensory Reactivity Phenotype in Phelan-McDermid Syndrome Is Distinct from Idiopathic ASD.
Tavassoli T; Layton C; Levy T; Rowe M; George-Jones J; Zweifach J; Lurie S; Buxbaum JD; Kolevzon A; Siper PM
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34206779
[TBL] [Abstract][Full Text] [Related]
55. Clinical characterization of novel chromosome 22q13 microdeletions.
Ha JF; Ahmad A; Lesperance MM
Int J Pediatr Otorhinolaryngol; 2017 Apr; 95():121-126. PubMed ID: 28576520
[TBL] [Abstract][Full Text] [Related]
56. Sleep disturbances in Phelan-McDermid syndrome: Clinical and metabolic profiling of 56 individuals.
Moffitt BA; Oberman LM; Beamer L; Srikanth S; Jain L; Cascio L; Jones K; Pauly R; May M; Skinner C; Buchanan C; DuPont BR; Kaufmann WE; Valentine K; Ward LD; Ivankovic D; Rogers RC; Phelan K; Sarasua SM; Boccuto L
Clin Genet; 2023 Aug; 104(2):198-209. PubMed ID: 37198960
[TBL] [Abstract][Full Text] [Related]
57. Chromothripsis and ring chromosome 22: a paradigm of genomic complexity in the Phelan-McDermid syndrome (22q13 deletion syndrome).
Kurtas N; Arrigoni F; Errichiello E; Zucca C; Maghini C; D'Angelo MG; Beri S; Giorda R; Bertuzzo S; Delledonne M; Xumerle L; Rossato M; Zuffardi O; Bonaglia MC
J Med Genet; 2018 Apr; 55(4):269-277. PubMed ID: 29378768
[TBL] [Abstract][Full Text] [Related]
58. Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome.
Dyar B; Meaddough E; Sarasua SM; Rogers C; Phelan K; Boccuto L
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440366
[TBL] [Abstract][Full Text] [Related]
59. [Phelan-McDermid syndrome associated with a novel heterozygous mutation in the SHANK3 gene].
I DV; Proskokova TN
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8):124-128. PubMed ID: 37655421
[TBL] [Abstract][Full Text] [Related]
60. Deep Phenotyping of Development, Communication and Behaviour in Phelan-McDermid Syndrome.
Droogmans G; Swillen A; Van Buggenhout G
Mol Syndromol; 2020 Jan; 10(6):294-305. PubMed ID: 32021603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
